Findlater Susan H
Department of Laboratory Medicine, Saint John Regional Hospital, Saint John, NB, Canada.
Clin Lab Sci. 2012 Summer;25(3):142-8.
The Cumulative Summation of Differences (CUSUM) is a recommended method for determining the consistency of one lot of Activated Partial Thromboplastin Time (APTT) reagent to another. This study investigates the usefulness of the CUSUM as a primary method for determining reagent suitability for APTT testing.
Results for lot comparison, reference range and Ex-Vivo heparin sensitivity studies were obtained using the Beckman Coulter ACL TOP coagulation analyzer. APTT testing was performed using HemosIL SynthASiL w/CaCl and Heparin Xa testing was performed using the HemosIL Liquid Heparin Assay. Samples from normal patients and from patients taking heparin were tested.
The CUSUM calculation showed a difference in APTT reagent lot means that is within the acceptable range for this method, suggesting that the reagents were comparable. Reference range and heparin sensitivity studies demonstrated a clinically significant difference between the two reagent lot numbers tested.
The CUSUM method of evaluating reagent lot variation of APTT reagents should be used with caution as it may not completely reflect the performance of the reagent. Clinically significant differences between reagent sensitivity may not be detected. The results of reference range and heparin sensitivity studies should also be considered when determining the suitability of APTT reagents. In addition, due to research evidence that using the APTT test for monitoring patient anticoagulation therapy is problematic, an evaluation of the benefits of using other study methods and multiple study methods is suggested as well as continued examination of the use of the APTT as the test of choice for UF heparin monitoring.
差异累积求和(CUSUM)是一种推荐的方法,用于确定一批活化部分凝血活酶时间(APTT)试剂与另一批试剂的一致性。本研究调查CUSUM作为确定APTT检测试剂适用性的主要方法的实用性。
使用贝克曼库尔特ACL TOP凝血分析仪获得批次比较、参考范围和体外肝素敏感性研究的结果。使用HemosIL SynthASiL w/CaCl进行APTT检测,使用HemosIL液体肝素测定法进行肝素Xa检测。对正常患者和服用肝素患者的样本进行检测。
CUSUM计算显示APTT试剂批次均值存在差异,但在该方法的可接受范围内,表明试剂具有可比性。参考范围和肝素敏感性研究表明,所测试的两个试剂批号之间存在临床显著差异。
评估APTT试剂批次差异的CUSUM方法应谨慎使用,因为它可能无法完全反映试剂的性能。可能无法检测到试剂敏感性之间的临床显著差异。在确定APTT试剂的适用性时,还应考虑参考范围和肝素敏感性研究的结果。此外,由于有研究证据表明使用APTT检测监测患者抗凝治疗存在问题,建议评估使用其他研究方法和多种研究方法的益处,并继续审查将APTT作为监测普通肝素的首选检测方法的使用情况。